Sophie Yancopoulos

Science Writer at The Feinstein Institute for Medical Research

Sophie Yancopoulos is a science writer at The Feinstein Institute for Medical Research.1 She specializes in writing about the intersections between evolution and cancer. As part of her role at the Feinstein Institute, she works with Dr. Nicholas Chiorazzi's research team, which focuses on studying B-lymphocytes in health and disease, particularly chronic lymphocytic leukemia (CLL).1

Background and Education

Sophie Yancopoulos has a strong academic background in both physics and biology:

She holds a B.A. and M.S. from Columbia University, where she studied Physics at Barnard College and Geophysics at the School of Engineering.5
She later pursued a Ph.D., indicating an advanced level of expertise in her field.2

Professional Experience

In addition to her work at the Feinstein Institute, Yancopoulos has diverse research experience:

She has collaborated with an international consortium of scientists on a project analyzing VH replacement, a cell DNA editing mechanism.2
Her research interests have included the role of internal water in transmembrane proteins, working with Dr. Mihaly Mezei and Dr. Roman Osman.3
She has also worked as a Scientific Grant Writer in Cancer Genomics at the New York Genome Center.4

Current Role and Research

At the Feinstein Institute, Sophie Yancopoulos contributes to cutting-edge research in immunology and cancer:

She is involved in studies combining the expression of hypervariably expressed genes with other prognostic factors in chronic lymphocytic leukemia.6
Her work supports the research efforts of Dr. Nicholas Chiorazzi's team, which has made significant contributions to understanding CLL and developing novel therapies.1

Sophie Yancopoulos's diverse background in physics and biology, combined with her expertise in science writing, allows her to effectively communicate complex scientific concepts and research findings in the field of medical research.